876275-35-3

Usage

Uses

Used in Pharmaceutical Research and Development:
Glycine, N-[2-(1,1-dimethylethoxy)-2-oxoethyl]-N-(4-formyl-2-oxo-2H-1-benzopyran-7-yl)-, 1,1-dimethylethyl ester is utilized as a key intermediate in the synthesis of new pharmaceutical compounds. Its unique structure and potential biological activity contribute to the development of innovative drugs for various medical conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Glycine, N-[2-(1,1-diMethylethoxy)-2-oxoethyl]-N-(4-forMyl-2-oxo-2H-1-benzopyran-7-yl)-, 1,1-diMethylethyl ester serves as a valuable research tool for understanding the structure-activity relationships of drug molecules. Its benzopyran ring and ester group provide a foundation for exploring the interactions between the compound and biological targets, such as enzymes, receptors, or other proteins, which may lead to the discovery of new therapeutic agents.
Used in Drug Design and Optimization:
The unique chemical features of Glycine, N-[2-(1,1-dimethylethoxy)-2-oxoethyl]-N-(4-formyl-2-oxo-2H-1-benzopyran-7-yl)-, 1,1-dimethylethyl ester make it a promising candidate for drug design and optimization. By modifying its structure, researchers can potentially enhance its pharmacological properties, such as potency, selectivity, and bioavailability, leading to the development of more effective and safer drugs.
Used in Drug Discovery:
As a derivative of glycine with a complex chemical structure, Glycine, N-[2-(1,1-diMethylethoxy)-2-oxoethyl]-N-(4-forMyl-2-oxo-2H-1-benzopyran-7-yl)-, 1,1-diMethylethyl ester is employed in drug discovery efforts to identify novel bioactive molecules. Its potential biological activity and unique features make it a valuable starting point for the development of new drugs targeting a wide range of diseases and conditions.

Downstream Products

• 876275-36-4 di-tert-butyl 2,2'-((4-(hydroxymethyl)-2-oxo-2H-chromen-7-yl)azanediyl)diacetate 
• 1031721-16-0 {7-[bis(carboxymethyl)amino]coumarin-4-yl}methyl phenylacetate